Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden

Authors:

Abstract
Low-risk prostate cancer has a prolonged natural history and can be safely managed with active surveillance and selective, deferred use of curative treatment. Despite this, recent US studies have reported that most low-risk prostate cancer is managed with immediate curative treatment,1 often reducing quality of life. Moreover, a recent modeling study showed that prostate cancer screening is generally not cost-effective based on current US treatment patterns but would be cost-effective if low-risk prostate cancer were managed conservatively.2 Although Sweden does not have a national screening program, more than 50% of Swedish men aged 55 to 69 years have been exposed to prostate-specific antigen (PSA) screening.3,4

This publication has 14 references indexed in Scilit: